- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT00580567
Impulsivity in Pathological Gambling
Impulsivity in Pathological Gambling: A Cross Sectional Analysis on Tests of Impulsivity Between Pathological Gamblers and a Non-pathological Control Group.
The purpose of the this study is to compare pathological gamblers versus non-pathological gamblers using tests that measure different components of impulsivity. We aim to invite a total of 120 individuals to participate in this study.
Impulsivity has been described as the cognitive inability to delay gratification, a failure to inhibit behavioral action or acting without forethought about consequences. Impulsivity has also been seen as a personality trait characterized by risk-taking or sensation seeking behavior. Pathological gamblers demonstrate aspects of impulsivity; they act without thinking, have difficult inhibiting urges to gamble and desire immediate gratification. The goal of this project is to clarify which components of impulsivity are associated with pathological gambling. Non-treatment seeking, pathological gamblers and controls will be recruited from the community and local casinos. Each participant will be administered a battery of tests that represent different operational definitions of impulsivity.
Descripción general del estudio
Estado
Condiciones
Descripción detallada
Tipo de estudio
Inscripción (Actual)
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
California
-
Los Angeles, California, Estados Unidos, 90095
- UCLA Neuropsychiatric Institute
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
Inclusion Criteria for Pathological Gamblers:
- 18 years or older
- Be able to speak, read and write in English
- Current diagnosis of pathological gambling (using DSM-IV criteria)
- South Oaks Gambling Screen (SOGS) score of 5 or above during screening
- Recent gambling activity -- at least once within one week prior to enrollment.
- Voluntarily given informed consent and signed the informed consent document.
- Not currently seeking treatment for gambling
Inclusion Criteria For Control Participants:
- 18 years or older
- Be able to speak, read and write in English
- South Oaks Gambling Screen (SOGS) score of 5 or less during screening
- Voluntarily given informed consent and signed the informed consent document
- Does not meet diagnosis of pathological gambling by DSM-IV criteria
- Not currently seeking treatment for gambling
Exclusion Criteria:
Exclusion Criteria for all participants:
- Current treatment for pathological gambling, excluding involvement with Gamblers Anonymous
- Ongoing medication for any psychiatric disorders, including anti-psychotics, antidepressants, mood stabilizers, anxiolytics or sedative/hypnotics.
- Dependence by DSM-IV criteria on any psychoactive substance, excluding caffeine or nicotine
- Presence of clinically unstable medical disorders that could harm the subject if not treated immediately.
- Presence of any neurological or psychiatric disorders (as assessed by the SCID or MINI and BDI-II) that would require immediate treatment.
- Test positive urine toxicology for illicit drugs prior to enrollment
- Hamilton Depression Scale score of >17
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
|---|
|
1
Pathological Gamblers
|
|
2
Non-Pathological Gamblers
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Periodo de tiempo |
|---|---|
|
Barratt Impusivity Scale
Periodo de tiempo: 12 months
|
12 months
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Timothy W. Fong, M.D., UCLA Gambling Studies Program
Publicaciones y enlaces útiles
Enlaces Útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- PA-00-004
- K23DA019522 (Subvención/contrato del NIH de EE. UU.)
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .